S.Amdt. 5391Senate117th Congress (2021-2023)2nd degree

S.Amdt. 5391

Submitted August 6, 2022

Legislative Activity

Stay on top of the latest movement without scrolling through every action

Floor Latest Action

Senate amendment submitted

August 6, 2022

Text

Submitted

SA 5391. Mr. MARSHALL submitted an amendment intended to be proposed
to amendment SA 5194 proposed by Mr. Schumer to the bill H.R. 5376, to
provide for reconciliation pursuant to title II of S. Con. Res. 14;
which was ordered to lie on the table; as follows:

At the end of part 1 of subtitle B of title I, add the
following:

SEC. 11005. CONSULTATION REQUIREMENT.

As a condition of implementing the provisions of, including
the amendments made by, section 11001 and 11002, the
Government Accountability Office shall to submit a report to
Congress with recommendations to ensure that the
implementation of such provisions does not--
(1) negatively impact the United States pharmaceutical
industry market competitiveness with China regarding
biopharmaceutical innovation and domestic manufacturing
capacity; or
(2) increase the United States' current importation levels
of essential generic drugs and drugs on the FDA shortages
list that are produced or manufactured by foreign entities in
China.
______